| Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence PJ Harrison, DR Weinberger Molecular psychiatry 10 (1), 40-68, 2005 | 2612 | 2005 |
| The neuropathology of schizophrenia: a critical review of the data and their interpretation PJ Harrison Brain 122 (4), 593-624, 1999 | 2289 | 1999 |
| Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis J Geddes, N Freemantle, P Harrison, P Bebbington Bmj 321 (7273), 1371-1376, 2000 | 1537 | 2000 |
| 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records M Taquet, JR Geddes, M Husain, S Luciano, PJ Harrison The Lancet Psychiatry 8 (5), 416-427, 2021 | 1516 | 2021 |
| Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA M Taquet, S Luciano, JR Geddes, PJ Harrison The Lancet Psychiatry 8 (2), 130-140, 2021 | 1302 | 2021 |
| Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond EM Tunbridge, PJ Harrison, DR Weinberger Biological psychiatry 60 (2), 141-151, 2006 | 941 | 2006 |
| Genes for schizophrenia? Recent findings and their pathophysiological implications PJ Harrison, MJ Owen The Lancet 361 (9355), 417-419, 2003 | 850 | 2003 |
| The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications PJ Harrison Psychopharmacology 174, 151-162, 2004 | 829 | 2004 |
| Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology PJ Harrison, AJ Law Biological psychiatry 60 (2), 132-140, 2006 | 554 | 2006 |
| The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis D Freeman, B Sheaves, GM Goodwin, LM Yu, A Nickless, PJ Harrison, ... The Lancet Psychiatry 4 (10), 749-758, 2017 | 540 | 2017 |
| Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 M Taquet, Q Dercon, S Luciano, JR Geddes, M Husain, PJ Harrison PLoS medicine 18 (9), e1003773, 2021 | 519 | 2021 |
| Inter-and intra-individual variability in alpha peak frequency S Haegens, H Cousijn, G Wallis, PJ Harrison, AC Nobre Neuroimage 92, 46-55, 2014 | 494 | 2014 |
| Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease AJ Law, BK Lipska, CS Weickert, TM Hyde, RE Straub, R Hashimoto, ... Proceedings of the National Academy of Sciences 103 (17), 6747-6752, 2006 | 485 | 2006 |
| Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge B Raman, MP Cassar, EM Tunnicliffe, N Filippini, L Griffanti, ... EClinicalMedicine 31, 100683, 2021 | 481 | 2021 |
| Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex EM Tunbridge, DM Bannerman, T Sharp, PJ Harrison Journal of Neuroscience 24 (23), 5331-5335, 2004 | 469 | 2004 |
| The neuropathology of primary mood disorder PJ Harrison Brain 125 (7), 1428-1449, 2002 | 446 | 2002 |
| Science and practice of cognitive behaviour therapy CG Fairburn, DM Clark Oxford University Press, 1997 | 434* | 1997 |
| The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain PWJ Burnet, SL Eastwood, K Lacey, PJ Harrison Brain research 676 (1), 157-168, 1995 | 376 | 1995 |
| The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded … PJ Harrison, PR Heath, SL Eastwood, PWJ Burnet, B McDonald, ... Neuroscience letters 200 (3), 151-154, 1995 | 374 | 1995 |
| 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia PWJ Burnet, SL Eastwood, PJ Harrison Neuropsychopharmacology 15 (5), 442-455, 1996 | 361 | 1996 |
